Nula Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $20.5M

  • Investors
  • 4

Nula Therapeutics General Information

Description

Operator of a biotechnology platform intended to develop therapies for metabolic dysfunction and age-related diseases through nuclear envelope targeting. The company offers small-molecule drug candidates focused on chronic disease treatment and healthspan research, enabling pharmaceutical researchers and healthcare providers to access novel therapeutic approaches for metabolic and age-related conditions.

Contact Information

Website
www.nulatx.com
Formerly Known As
Apollo Alpha
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 961 Arlington Avenue North
  • St. Petersburg, FL 33705
  • United States
+1 (412)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 961 Arlington Avenue North
  • St. Petersburg, FL 33705
  • United States
+1 (412)

Nula Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nula Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 24-Feb-2026 $20.5M Completed Clinical Trials - Phase 1
2. Later Stage VC (Series 1) Completed Clinical Trials - Phase 1
1. Seed Round 18-Mar-2026 $7.4M $7.4M Completed Clinical Trials - Phase 1
To view Nula Therapeutics’s complete valuation and funding history, request access »

Nula Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed 4,281,288 $0.000100 $0.7 $0.7 1x $0.7 20.99%
To view Nula Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nula Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nula Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apollo Health Ventures Venture Capital Minority
GIMIC Ventures Venture Capital Minority
Korify Capital Venture Capital Minority
ARPA-H Government
To view Nula Therapeutics’s complete investors history, request access »

Nula Therapeutics FAQs

  • When was Nula Therapeutics founded?

    Nula Therapeutics was founded in 2021.

  • Where is Nula Therapeutics headquartered?

    Nula Therapeutics is headquartered in St. Petersburg, FL.

  • What is the size of Nula Therapeutics?

    Nula Therapeutics has 14 total employees.

  • What industry is Nula Therapeutics in?

    Nula Therapeutics’s primary industry is Biotechnology.

  • Is Nula Therapeutics a private or public company?

    Nula Therapeutics is a Private company.

  • What is Nula Therapeutics’s current revenue?

    The current revenue for Nula Therapeutics is .

  • How much funding has Nula Therapeutics raised over time?

    Nula Therapeutics has raised $17.4M.

  • Who are Nula Therapeutics’s investors?

    Apollo Health Ventures, GIMIC Ventures, Korify Capital, and ARPA-H have invested in Nula Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process